CYTOCELL LIMITED
CytoCell Limited, a UK molecular cytogenetics brand of Oxford Gene Technology, sells over 545 FISH probes and custom probe services for clinical and research laboratories in haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications.
- Company typePrivate
- Founded2000
- Headquarters—
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CYTOCELL LIMITED does
CytoCell Limited, operating under the legal entity Oxford Gene Technology IP Limited, is a privately held UK molecular cytogenetics company headquartered in Cambridge with a 2000 founding date and 13 reported employees. Its flagship offering is a fluorescence in situ hybridisation (FISH) probe portfolio of over 545 ready-to-order products spanning haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications, plus a custom probe design service branded myProbes. The FISH probes are sold either as Research Use Only (RUO) products or as IVDR-certified probes for diagnostic use in Europe, supported by laboratory accessories (tissue pretreatment kits, microscope filters, hybridisation chambers, buffers) and an integrated imaging/analysis partnership with Applied Spectral Imaging (ASI). The portfolio extends beyond FISH into SureSeq next-generation sequencing and CytoSure aCGH microarray sub-brands, positioning the company across multiple cytogenetics and genomics modalities.
The business model centres on one-time/perpetual licence sales of FISH probes and accessories with pay-as-you-go billing, supplemented by multi-year contracts for custom probe development through the myProbes service. Pricing is not publicly disclosed; customers engage via direct consultative sales (phone and email) with contact routed through the parent OGT infrastructure. Go-to-market is enterprise field sales targeting research laboratories, hospitals, and genetics centres globally, with dedicated regional websites for the UK, USA, and Canada markets. Customer evidence includes NHS hospitals, US academic medical centres, government institutes, and commercial genetics laboratories across the UK, USA, Canada, and Serbia, with several relationships spanning two decades. The company also operates a DNA Dispatch newsletter, online product documentation portal, and customer testimonial-driven content marketing channel.
CYTOCELL LIMITED firmographics
Firmographics- Name
- CYTOCELL LIMITED
- Legal name
- Oxford Gene Technology IP Limited
- Website
- https://cytocell.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CytoCell Limited, a UK molecular cytogenetics brand of Oxford Gene Technology, sells over 545 FISH probes and custom probe services for clinical and research laboratories in haematology, solid tumour, cytogenetics, rare disease, and prenatal testing applications.
- Ownership category
- akta.pro rank
CYTOCELL LIMITED industry classification
Industry- Product category
- Cytogenetic Diagnostics Reagents
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV) (HLAGANAJ)
- akta.pro secondary industries
- Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
CYTOCELL LIMITED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others
Revenue model
- FISH Probes and Accessories Sales: Sale of ready-to-order IVDD and RUO FISH probes along with supporting accessories including tissue pretreatment kits, microscope filters, hybridisation chambers, and buffers
- Custom FISH Probe Development: myProbes customisation service for developing bespoke FISH probes tailored to specific laboratory requirements
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Research Use Only (RUO) FISH probes |
| One time/ perpetual license | Pay-as-you-go | IVDR-certified FISH probes |
| Other | Multi-year contract | Custom FISH probe development (myProbes) |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CYTOCELL LIMITED product offering
Product offeringCore offering
CytoCell Limited, operating under Oxford Gene Technology (OGT), manufactures and sells a comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes used by clinical cytogenetics laboratories to detect genetic abnormalities in haematological malignancies, solid tumours, constitutional cytogenetics, and rare diseases. Offerings span ready-to-order IVDD/RUO and IVDR-certified probes, the myProbes custom FISH probe design service, complementary FISH laboratory accessories, as well as OGT's adjacent SureSeq NGS and CytoSure aCGH microarray product lines.
Product overview
CytoCell Limited, operating under Oxford Gene Technology (OGT), offers a comprehensive molecular diagnostics portfolio comprising FISH probes as its core product line alongside complementary NGS (SureSeq) and aCGH microarray (CytoSure) platforms. The CytoCell FISH portfolio represents the primary offering with over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications, supported by IVDR-certified probes, custom probe design services (myProbes), FISH imaging and analysis solutions, and laboratory accessories. The SureSeq NGS and CytoSure Arrays brands extend the portfolio into next-generation sequencing and microarray-based genomic analysis.
Differentiator
Problem solved
Functional benefit
Brands
- CytoCell: World-leading fluorescence in situ hybridisation (FISH) probes product portfolio including over 545 probes for haematology, solid tumour, cytogenetics, and rare disease applications.
- CytoSure
- SureSeq
- myProbes
Products and services
- CytoCell FISH Probes Comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes covering haematology, solid tumour, cytogenetics, and rare disease applications, with IVDD/RUO and IVDR-certified variants. Designed for clinical cytogenetics laboratories, hospitals, and genetics centres.
- CytoCell IVDR-Certified FISH Probes
Quantifiable outcome
- Over 545 ready-to-order IVDD and RUO FISH probes available
- +3 more outcomes
Companies that use CYTOCELL LIMITED
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
CYTOCELL LIMITED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CYTOCELL LIMITED partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
CYTOCELL LIMITED competitors and assessment
Company assessmentBroad incumbents
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights1 record
Customer concentration
CYTOCELL LIMITED social profiles
Digital presenceCYTOCELL LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
CYTOCELL LIMITED leadership team
Management profileNumber of profiles
CYTOCELL LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CYTOCELL LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CYTOCELL LIMITED
What does CYTOCELL LIMITED do?
CytoCell Limited, operating under Oxford Gene Technology (OGT), manufactures and sells a comprehensive portfolio of over 545 fluorescence in situ hybridisation (FISH) DNA probes used by clinical cytogenetics laboratories to detect genetic abnormalities in haematological malignancies, solid tumours, constitutional cytogenetics, and rare diseases. Offerings span ready-to-order IVDD/RUO and IVDR-certified probes, the myProbes custom FISH probe design service, complementary FISH laboratory accessories, as well as OGT's adjacent SureSeq NGS and CytoSure aCGH microarray product lines.
Is CYTOCELL LIMITED a public or private company?
CYTOCELL LIMITED is a private company. It is classified as unknown and is currently operating.
When was CYTOCELL LIMITED founded?
CYTOCELL LIMITED was founded in 2000. It employs 11 to 50 people.
How does CYTOCELL LIMITED make money?
Two revenue lines are on record. FISH Probes and Accessories Sales are the primary driver. The others are custom FISH Probe Development.
Who are CYTOCELL LIMITED's main competitors?
Abbott Molecular is listed as a broad incumbent.
Does CYTOCELL LIMITED have an API?
No public API is recorded for CYTOCELL LIMITED.
What industry is CYTOCELL LIMITED in?
CYTOCELL LIMITED's product category is Cytogenetic Diagnostics Reagents. Its primary akta.pro industry code is HLAGANAJ, Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV), with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 541714 and its SIC code is 2835.